Patrick Industries (PATK) had the highest return in March 2012 by a mid-cap US stock, returning 97.2%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Patrick Industries (PATK) | March 2012 | 97.24% |
Sarepta Therapeutics (SRPT) | March 2012 | 49.51% |
IES (IESC) | March 2012 | 45.28% |
Frontline (FRO) | March 2012 | 39.56% |
Caesars Entertainment (CZR) | March 2012 | 35.64% |
Addus HomeCare (ADUS) | March 2012 | 33.42% |
Vera Therapeutics (VERA) | March 2012 | 32.45% |
Repligen (RGEN) | March 2012 | 31.4% |
ACADIA Pharmaceuticals (ACAD) | March 2012 | 27.98% |
Alphatec (ATEC) | March 2012 | 25.4% |
ASGN (ASGN) | March 2012 | 24.79% |
Nova (NVMI) | March 2012 | 20.92% |
Bancorp (TBBK) | March 2012 | 20.1% |
American Eagle Outfitters (AEO) | March 2012 | 18.68% |
Pilgrims Pride (PPC) | March 2012 | 18.41% |
Littelfuse (LFUS) | March 2012 | 18.24% |
Arrowhead Pharmaceuticals (ARWR) | March 2012 | 18.15% |
Federal Signal (FSS) | March 2012 | 18.05% |
Trex (TREX) | March 2012 | 17.98% |
St Joe (JOE) | March 2012 | 17.93% |
Terawulf (WULF) | March 2012 | 17.27% |
HCI (HCI) | March 2012 | 16.62% |
Civitas Resources (CIVI) | March 2012 | 16.6% |
Scotts Miracle-Gro (SMG) | March 2012 | 15.14% |
Grupo Simec SAB de CV ADR (SIM) | March 2012 | 14.55% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
